The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
Recruiting · NCT06675344 · Registry updated 2026-01-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life | Embolism and Thrombosis, Fatigue, Pathological Conditions, Signs and Symptoms, Raynaud disease, Signs and Symptoms, Skin and Connective Tissue Diseases, cardiovascular disorder, connective tissue disorder, diffuse scleroderma, livedoid vasculopathy, peripheral vascular disease, skin disorder, skin vascular disease, systemic sclerosis, thrombotic disease, vascular disorder | Recruiting | Not applicable | 2026-01-08 | NCT06675344 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Robyn T. Domsic, MD, MPH | 2 |
| United States Department of Defense | 319 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| DelRicht Research Center | New Orleans | United States | 1 |
| University of Michigan | Ann Arbor | United States | 538 |
| University of Pittsburgh and UPMC Scleroderma Center | Pittsburgh | United States | 1 |
| Vanderbilt University Medical Center | Nashville | United States | 427 |